Bank of New York Mellon’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-18,625
| Closed | -$97K | – | 4407 |
|
|
2016
Q4 | $97K | Sell |
18,625
-1,200
| -6% | -$5.64K | ﹤0.01% | 4033 |
|
|
2016
Q3 | $92K | Sell |
19,825
-3,238
| -14% | -$15.1K | ﹤0.01% | 4065 |
|
|
2016
Q2 | $91K | Sell |
23,063
-100
| -0.4% | -$374 | ﹤0.01% | 4078 |
|
|
2016
Q1 | $71K | Sell |
23,163
-14,227
| -38% | -$47.7K | ﹤0.01% | 4034 |
|
|
2015
Q4 | $170K | Sell |
37,390
-133,458
| -78% | -$633K | ﹤0.01% | 3916 |
|
|
2015
Q3 | $805K | Buy |
170,848
+5,915
| +4% | +$38.2K | ﹤0.01% | 3319 |
|
|
2015
Q2 | $1.18M | Sell |
164,933
-19,509
| -11% | -$147K | ﹤0.01% | 3238 |
|
|
2015
Q1 | $1.56M | Buy |
184,442
+4,934
| +3% | +$42K | ﹤0.01% | 3034 |
|
|
2014
Q4 | $1.67M | Buy |
179,508
+4,834
| +3% | +$42K | ﹤0.01% | 2985 |
|
|
2014
Q3 | $1.46M | Buy |
174,674
+7,379
| +4% | +$68.3K | ﹤0.01% | 3074 |
|
|
2014
Q2 | $1.93M | Buy |
167,295
+42,084
| +34% | +$432K | ﹤0.01% | 2923 |
|
|
2014
Q1 | $1.59M | Buy |
125,211
+8,913
| +8% | +$115K | ﹤0.01% | 3032 |
|
|
2013
Q4 | $1.26M | Buy |
116,298
+73,512
| +172% | +$854K | ﹤0.01% | 3164 |
|
|
2013
Q3 | $530K | Buy |
42,786
+1,030
| +2% | +$14.2K | ﹤0.01% | 3505 |
|
|
2013
Q2 | $558K | Buy |
+41,756
| New | +$537K | ﹤0.01% | 3458 |
|
Other funds holding DSCI
Bank of New York Mellon's DSCI Position: Q1 2017 in Review
Bank of New York Mellon sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 18,625 shares — an estimated $97K sold.
Bank of New York Mellon first reported a position in DSCI in Q2 2013 and held it in 15 quarters. The position peaked at $1.93M in Q2 2014. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.
- Bank of New York Mellon reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
- Bank of New York Mellon sold 18,625 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $97K.
- Bank of New York Mellon first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 15 quarters.
- Bank of New York Mellon's Derma Sciences, Inc. Common Stock (DE) position peaked at $1.93M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.
Based on Bank of New York Mellon's 13F filing for Q1 2017, filed 3 May 2017.